Fisher's non-discretionary sale reduced her direct holdings by 5%, leaving $3.67 million in remaining equity. The transaction occurred as HubSpot faced a -52% one-year return.
Kaltura (NASDAQ:KLTR) reported second-quarter 2026 results above the high end of its guidance range, citing subscription revenue growth, record non-GAAP gross margin and growing early commercial activity for its artificial-intelligence products.
Total revenue for the quarter ended June 30 was $46.9
Lifecore Biomedical (NASDAQ:LFCR) reaffirmed its 2026 revenue and adjusted EBITDA guidance while outlining plans to support sharply higher fill-finish demand from its largest customer beginning in 2027.
For the second quarter ended June 30, 2026, the contract development and manufacturing organizat
1stdibs.com (NASDAQ:DIBS) reported second-quarter results that exceeded its guidance range, with gross merchandise value (GMV) returning to year-over-year growth despite continued weakness in the luxury home-furnishings market and lower sales and marketing spending.
GMV rose 7% to $96 million in th
Geron (NASDAQ:GERN) reported second-quarter net revenue of $57.5 million, up 17% from a year earlier and 11% sequentially, as the company continued to expand use of RYTELO among patients with lower-risk myelodysplastic syndromes, or MDS.
Chief Executive Officer Harout Semerjian said first-half net
Bloomin' Brands (NASDAQ:BLMN) reported fiscal second-quarter 2026 revenue of $1.02 billion, up 1% from $1 billion a year earlier, as positive comparable restaurant sales helped offset continued traffic pressure at several of its brands.
The company said U.S. comparable restaurant sales increased 2.
Compass Pathways (NASDAQ:CMPS) said it remains on track to complete its new drug application, or NDA, filing for COMP360 in treatment-resistant depression in the fourth quarter of 2026, following positive Phase III results and six-month durability data from two trials.
Chief Executive Officer Kabir
Aurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following reimbursement changes and the company’s planned exit from lower-margin Canadian consumer cannabis op
Acacia Research (NASDAQ:ACTG) reported second-quarter 2026 revenue of $114.6 million, up from $51.2 million in the prior-year period, as licensing activity in its intellectual property business and contributions from its operating companies supported results.
The company posted operating income of
Klöckner & Co SE (ETR:KCO) reported second-quarter 2026 EBITDA before material special effects of €63 million, placing the steel and metal distributor in the upper half of its full-year guidance range, as higher pricing and growth in its European business supported results.
CEO Guido Kerkhoff said
ElringKlinger (ETR:ZIL2) reported higher second-quarter revenue and earnings for 2026, driven by growth in its e-mobility operations, cost-control measures and improved cash generation, while maintaining its full-year and medium-term outlook amid a weakening global vehicle-production environment.
R
Snack food company Utz Brands (NYSE:UTZ) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.4% year on year to $371.8 million....
Outdoor advertising company Clear Channel Outdoor (NYSE:CCO) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $438 mi...
Fast-food chain Shake Shack (NYSE:SHAK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 17.2% year on year to $417.6 million. Its non-GAAP...
